Clinical Trials · NCT02542501

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues

Name: Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/AGonadorelin

Phase: N/A
Recruitment status: Completed
Sponsor: Ipsen
Enrollment: 470
Start date: Jul 2015
Locations: 32 sites, Portugal, Spain
Primary endpoint: The number of patients having Lower Urinary Tract Symptoms (LUTS) at baseline.

View Gonadorelin compound reference